GB9626441D0 - A method for inhibiting activation of the human A3 adenosine receptor - Google Patents

A method for inhibiting activation of the human A3 adenosine receptor

Info

Publication number
GB9626441D0
GB9626441D0 GBGB9626441.1A GB9626441A GB9626441D0 GB 9626441 D0 GB9626441 D0 GB 9626441D0 GB 9626441 A GB9626441 A GB 9626441A GB 9626441 D0 GB9626441 D0 GB 9626441D0
Authority
GB
United Kingdom
Prior art keywords
human
adenosine receptor
inhibiting activation
inhibiting
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9626441.1A
Other versions
GB2320430A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB9626441A priority Critical patent/GB2320430A/en
Publication of GB9626441D0 publication Critical patent/GB9626441D0/en
Publication of GB2320430A publication Critical patent/GB2320430A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9626441A 1996-12-20 1996-12-20 Inhibiting activation of the human A3 adenosine receptor Withdrawn GB2320430A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9626441A GB2320430A (en) 1996-12-20 1996-12-20 Inhibiting activation of the human A3 adenosine receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9626441A GB2320430A (en) 1996-12-20 1996-12-20 Inhibiting activation of the human A3 adenosine receptor

Publications (2)

Publication Number Publication Date
GB9626441D0 true GB9626441D0 (en) 1997-02-05
GB2320430A GB2320430A (en) 1998-06-24

Family

ID=10804724

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9626441A Withdrawn GB2320430A (en) 1996-12-20 1996-12-20 Inhibiting activation of the human A3 adenosine receptor

Country Status (1)

Country Link
GB (1) GB2320430A (en)

Also Published As

Publication number Publication date
GB2320430A (en) 1998-06-24

Similar Documents

Publication Publication Date Title
EP0908024A4 (en) Packet-switched spread-spectrum system
AU128946S (en) Bowl
GB9507984D0 (en) Inhibition of eosinophil activation through A3 adenosine receptor antagonism
TW308062U (en) Bidet apparatus
EP0828751A4 (en) Human neuropeptide receptor
EP0832125A4 (en) Human g-protein receptor hgber32
EP0853629A4 (en) Hepadnavirus receptor
GB2300370B (en) Foul release system
GB9517098D0 (en) Receptor
GB2309893B (en) Adjustment device for the longitudinal adjustment of a seat
EP0832122A4 (en) Human g-protein receptor hpraj70
GB2298252B (en) Procedure for gearbox-type determination
EP0835264A4 (en) Human g-protein receptor hcegh45
EP0792282A4 (en) Human endothelin-bombesin receptor
GB9507139D0 (en) Release units
GB9626441D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
GB9603451D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
GB9616590D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
EP0832124A4 (en) Human amine receptor
GB2308509B (en) Services-connections for trailer-vehicles
EP0933647A4 (en) Pulse radio-localisation system
GB2304053B (en) Stump-socks for amputees
GB2308393B (en) Windshelter for sun-bathing
GB9610365D0 (en) Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor
EP0871668A4 (en) Human g-protein receptor hibef51

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)